Ekso Bionics Holdings Inc
(EKSO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,638 | -81,766 | -31 | -9,091 | -7,197 |
| Depreciation Amortization | 513 | 346 | 623 | 448 | 474 |
| Accounts receivable | -944 | -1,226 | 239 | 123 | -129 |
| Accounts payable and accrued liabilities | -272 | -454 | 4 | 195 | -220 |
| Other Working Capital | -1,173 | -1,843 | 0 | 611 | 139 |
| Other Operating Activity | 18,909 | 79,484 | -866 | 952 | 1,318 |
| Operating Cash Flow | $-8,605 | $-5,459 | $-31 | $-6,762 | $-5,614 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -675 | -248 | -379 | -50 | -97 |
| Investing Cash Flow | $-675 | $-248 | $-379 | $-50 | $-97 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 2 | 2,000 | 2,000 |
| Debt Repayment | -2,544 | -2,532 | -1,829 | -1,046 | -898 |
| Common Stock Issued | 21,984 | 22,010 | -743 | 52 | 56 |
| Other Financing Activity | 0 | 0 | 2,572 | 4,294 | 2,968 |
| Financing Cash Flow | $19,440 | $19,478 | $2 | $5,300 | $4,127 |
| Beginning Cash Position | 805 | 805 | 29 | 1,739 | 1,739 |
| End Cash Position | 10,965 | 14,576 | 0 | 227 | 154 |
| Net Cash Flow | $10,160 | $13,771 | $-29 | $-1,512 | $-1,584 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,605 | -5,459 | -31 | -6,762 | -5,614 |
| Capital Expenditure | -675 | -248 | -379 | -50 | -97 |
| Free Cash Flow | -9,280 | -5,707 | -410 | -6,811 | -5,711 |